Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Robertson

Showing results (531-540 of 565) with videos related to

Pageof 57
Sort By:
Journal of Gastroenterology and Hepatology|October 13, 2018
Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia-Pacific region and Russia: Final results from the randomized C-CORAL studyLai Wei, Ji Dong Jia, Fu Sheng Wang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 26, 2019
Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized studyTarik Asselah, Stanislas Pol, Christophe Hezode, et al.
PLOS Global Public Health|October 24, 2024
Promising results of HIV prevention trials highlight the benefits of collaboration in global health: The perspective of the Forum HIV Recency Assay Working GroupRobin Schaefer, Logan Donaldson, Mitchell Leus, et al.
Annals of Internal Medicine|August 19, 2016
Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized TrialGregory J Dore, Frederick Altice, Alain H Litwin, et al.
The Lancet. Infectious Diseases|September 22, 2011
Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trialJoseph J Eron, Jürgen K Rockstroh, Jacques Reynes, et al.
NPJ Precision Oncology|January 29, 2025
Genetic ancestry concordant RNA splicing in prostate cancer involves oncogenic genes and associates with recurrenceMuthana Al Abo, Wen-Chi Foo, Lauren E Howard, et al.
Nature Communications|August 24, 2024
PHF6 cooperates with SWI/SNF complexes to facilitate transcriptional progressionPriya Mittal, Jacquelyn A Myers, Raymond D Carter, et al.
Journal of Medicinal Chemistry|July 25, 2017
Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related BiomarkersNahoum G Anthony, Jessica Baiget, Giacomo Berretta, et al.
Nucleic Acids Research|December 31, 2005
cisRED: a database system for genome-scale computational discovery of regulatory elementsG Robertson, M Bilenky, K Lin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
NCCN clinical practice guidelines in oncology: testicular cancerRobert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Pageof 57

Showing results (531-540 of 565) with videos related to

Sort By:
Pageof 57
Journal of Gastroenterology and Hepatology|October 13, 2018
Efficacy and safety of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1, 4, or 6 infection from the Asia-Pacific region and Russia: Final results from the randomized C-CORAL studyLai Wei, Ji Dong Jia, Fu Sheng Wang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 26, 2019
Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized studyTarik Asselah, Stanislas Pol, Christophe Hezode, et al.
PLOS Global Public Health|October 24, 2024
Promising results of HIV prevention trials highlight the benefits of collaboration in global health: The perspective of the Forum HIV Recency Assay Working GroupRobin Schaefer, Logan Donaldson, Mitchell Leus, et al.
Annals of Internal Medicine|August 19, 2016
Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized TrialGregory J Dore, Frederick Altice, Alain H Litwin, et al.
The Lancet. Infectious Diseases|September 22, 2011
Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trialJoseph J Eron, Jürgen K Rockstroh, Jacques Reynes, et al.
NPJ Precision Oncology|January 29, 2025
Genetic ancestry concordant RNA splicing in prostate cancer involves oncogenic genes and associates with recurrenceMuthana Al Abo, Wen-Chi Foo, Lauren E Howard, et al.
Nature Communications|August 24, 2024
PHF6 cooperates with SWI/SNF complexes to facilitate transcriptional progressionPriya Mittal, Jacquelyn A Myers, Raymond D Carter, et al.
Journal of Medicinal Chemistry|July 25, 2017
Inhibitory Kappa B Kinase α (IKKα) Inhibitors That Recapitulate Their Selectivity in Cells against Isoform-Related BiomarkersNahoum G Anthony, Jessica Baiget, Giacomo Berretta, et al.
Nucleic Acids Research|December 31, 2005
cisRED: a database system for genome-scale computational discovery of regulatory elementsG Robertson, M Bilenky, K Lin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
NCCN clinical practice guidelines in oncology: testicular cancerRobert J Motzer, Neeraj Agarwal, Clair Beard, et al.
Pageof 57